Covid-19: EU strikes deal for up to 405m doses of potential vaccine

Agreement takes the total number of vaccine supplies secured by bloc to nearly 2bn doses

European Commission president Ursula von der Leyen has confirmed  a new agreement to buy up to 405m doses of a potential Covid-19 vaccine. Photograph: Kenzo Tribouillard/EPA

European Commission president Ursula von der Leyen has confirmed a new agreement to buy up to 405m doses of a potential Covid-19 vaccine. Photograph: Kenzo Tribouillard/EPA

The EU has struck a deal for up to 405 million doses of German biotech firm CureVac’s potential Covid-19 vaccine, the head of the EU executive said on Monday, taking total vaccine supplies secured by the bloc to nearly 2 billion doses.

The deal with CureVac follows EU supply agreements with AstraZeneca, Johnson & Johnson, Sanofi, and Pfizer for a combined 1.4 billion doses of their potential vaccines.

Please subscribe or sign in to continue reading.
only €1 first month

Insightful opinion is just a away.